Mubasher: The Jordanian Pharmaceutical Manufacturing Company reported a 45% decline in losses in the third quarter of 2016 to JOD 2.03 million ($2.85 million) compared to JOD 3.7 million ($5.2 million) in the same quarter last year.

Losses also went down by 69.9% in the first nine months of the year to JOD 2.97 million from losses of JOD 9.9 million in the same period in 2015, the company said in a bourse filing on Wednesday.